Insider Trading & Ownership - Oxtoby Andrew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Oxtoby Andrew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-13
Sale
2020-10-14
4:15 pm
Aimmune Therapeutics Inc. AIMT Oxtoby Andrew
Chief Commercial Officer
20,250 $34.5 $698,625 0
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-04-10
Option Award
2025-04-11
4:55 pm
N/A
2035-04-09
Kalaris Therapeutics Inc. KLRS Oxtoby Andrew
See Remarks
287,000 $0 287,000
(Direct)
View
2025-03-18
Option Award
2025-03-18
5:41 pm
N/A
2034-05-27
Kalaris Therapeutics Inc. KLRS Oxtoby Andrew
See Remarks
476,611 $0 476,611
(Direct)
View
2023-02-28
Option Award
2023-03-02
5:00 pm
N/A
2033-02-27
CHINOOK THERAPEUTICS INC. KDNY Oxtoby Andrew
Chief Commercial Officer
200,000 $0 200,000
(Direct)
View
2020-10-10
Equity Swap
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Oxtoby Andrew
Chief Commercial Officer
6,345 $34.5 0
(Direct)
View
2020-09-15
Tax Withholding
2020-09-16
5:19 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Oxtoby Andrew
Chief Commercial Officer
840 $34.25 26,595
(Direct)
View
2020-05-10
Option Award
2020-05-12
5:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Oxtoby Andrew
Chief Commercial Officer
2,420 $0 27,435
(Direct)
View